- May 8, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
viberzi
Synonyms :
Eluxadoline
Class :
Mu-receptor agonists, IBS agents
Dosage Forms & Strengths
Tablet
75mg
100mg
irritable bowel syndrome (IBS)
100
mg
Orally
Twice a day after meal
Tablet
may enhance the serum concentration of BCRP/ABCG2 inhibitors
may enhance the serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) inhibitors
may enhance the serum concentration of BCRP/ABCG2 inhibitors
may enhance the serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) inhibitors
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration of OATP1/1B3 substrates
acrivastine and pseudoephedrine
may increase the constipating effect of anticholinergic agents
may enhance the serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Inhibitors
may enhance the serum concentration of OATP1B1/1B3 (SLCO1B1/1B3) Inhibitors
may have an increased Effect of CNS depressant when combined with opioid agonists
may have an increased Effect of CNS depressant when combined with opioid agonists
may have an increased Effect of CNS depressant when combined with opioid agonists
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
may enhance the constipation effect
may enhance the constipation effect
may enhance the constipation effect
may enhance the constipation effect
may enhance the constipation effect
may increase the constipation effect of opioid agonist
may increase the constipation effect of opioid agonist
may increase the constipation effect of opioid agonist
may increase the constipation effect of opioid agonist
may increase the constipation effect of opioid agonist
opioid agonists increase the effect of constipation of eluxadoline
opioid agonists increase the effect of constipation of eluxadoline
may enhance the serum concentration
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
may have an increased constipating effect when combined with eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
anticholinergic agents increase the effect of constipation of eluxadoline
It may enhance the effects when combined with sufentanil by pharmacodynamic synergism
It may enhance the effect when combined with pharmacodynamic synergism
It may enhance the levels when combined with rosiglitazone by diminishing metabolism
eluxadoline: they may increase the CNS depressant effect of CNS Depressants
eluxadoline: they may increase the CNS depressant effect of CNS Depressants
eluxadoline: they may increase the CNS depressant effect of CNS Depressants
it increases the effect of constipation of anticholinergic agents
it increases the effect of constipation of anticholinergic agents
it increases the effect of constipation of anticholinergic agents
it increases the effect of constipation of anticholinergic agents
it increases the effect of constipation of anticholinergic agents
when both drugs are combined, there may be an increased level of serum concentration of alpelisib
the level of lenvatinib increases due to a decrease in metabolism by eluxadoline
both, when used simultaneously, increases the effect of the other by synergistic activity
it may increase the constipating effect of Eluxadoline
it may increase the constipating effect of eluxadoline
it may increase the constipating effect of eluxadoline
it may increase the constipating effect of eluxadoline
may increase the metabolism of each other
may increase the constipation effect of opioid agonist
may enhance the constipating effect of opioid agonist
hydrocodone/chlorpheniramine/pseudoephedrine
may increase the constipation activity
alosetron increases the effect of constipation of eluxadoline
opioid agonists increase the effect of constipation of eluxadoline
it decreases the effect of opioid agonists
they decrease the effect of analgesia of opioid agonists
they decrease the effect of analgesia of opioid agonists
they decrease the effect of analgesia of opioid agonists
it decreases the efficacy of opioid agonists
may increase the constipating effect of anticholinergic agents
may increase the CNS depressant effect
may increase the constipating effects of opioid agonist
may increase the constipating effect of anticholinergic agents
may increase the constipating effect of anticholinergic agents
may increase the constipating effect of Anticholinergic Agents
may increase the constipating effect of Anticholinergic Agents
may increase the constipating effect of Anticholinergic Agents
may increase the constipating effect of Opioid Agonists
OATP1B1/1B3 inhibitors increase the concentration of eluxadoline in the serum
OATP1B1/1B3 inhibitors increase the concentration of eluxadoline in the serum
OATP1B1/1B3 inhibitors increase the concentration of eluxadoline in the serum
OATP1B1/1B3 inhibitors increase the concentration of eluxadoline in the serum
OATP1B1/1B3 inhibitors increase the concentration of eluxadoline in the serum
spironolactone and hydrochlorothiazide
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of diuretics
mu-opioid receptor agonists: they may increase the toxic effect of loop diuretics
mu-opioid receptor agonists: they may increase the toxic effect of loop diuretics
mu-opioid receptor agonists: they may increase the toxic effect of loop diuretics
when thiotepa and eluxadoline combine, thiotepa increases levels of eluxadoline by affecting the enzyme cyp2b6 metabolism